Efficacy of Intravenous Tenecteplase Bridge Thrombectomy for Recurrent Ischemic Stroke Within 3 Months: A Case Report
Cuicui Liu, Junyan Liu, Huiling Ren, Yuzhu Xu, Wanhu Liu Department of Neurology, The Third Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of ChinaCorrespondence: Wanhu Liu, Department of Neurology, The Third Hospital of Hebei Medical University, 139 Ziqiang Road, Shijiazhuang...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-02-01
|
| Series: | International Medical Case Reports Journal |
| Subjects: | |
| Online Access: | https://www.dovepress.com/efficacy-of-intravenous-tenecteplase-bridge-thrombectomy-for-recurrent-peer-reviewed-fulltext-article-IMCRJ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Cuicui Liu, Junyan Liu, Huiling Ren, Yuzhu Xu, Wanhu Liu Department of Neurology, The Third Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of ChinaCorrespondence: Wanhu Liu, Department of Neurology, The Third Hospital of Hebei Medical University, 139 Ziqiang Road, Shijiazhuang, 050000, People’s Republic of China, Email [email protected]: In the previous guideline recommendations, patients who have had a stroke within 3 months are excluded from intravenous thrombolysis (IVT) regimens. Some studies have suggested that IVT with alteplase (rt-PA) may be effective and safe in such patients, but evidence supporting the use of tenecteplase (TNK) is not sufficient. This paper includes an 80-year-old male patient readmitted for recurrence of ischaemic stroke (IS) after 48 days, who received TNK IVT as a bridging therapy prior to thrombectomy, with favourable results at 8-week follow-up. This case highlights that TNK alone or IVT as a bridging therapy prior to thrombectomy can also benefit patients with recurrent stroke within 3 months.Keywords: intravenous thrombolysis, recurrent ischemic stroke, tenecteplase |
|---|---|
| ISSN: | 1179-142X |